H
Loading...
Loading...
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Census population 383,997. Louisiana Medicare wound biologics: Novitas Solutions (JH). Hawk Medical is a national HCT/P 361 and wound-care distributor serving licensed New Orleans clinics — not a walk-in office.
Written for licensed providers. Reviewed by Joe Bradley, Founder & CEO. Content version 2026-09-18. Hawk Medical ships nationwide — this is not a New Orleans storefront.
Joint Preservation Therapy Solutions in New Orleans, LA for clinics & physicians. Joint preservation thera… Compliance support & pricing — contact Hawk Medical.
CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Obesity 34%; arthritis 25.3%. Those three PLACES crude rates (plus Census 383,997) are the local facts on this page. Everything else is the national joint preservation therapy catalog and JH paperwork.
National Joint Preservation Therapy Solutions notes (how the product actually works)Louisiana shares JH with AR, CO, MS, NM, OK, TX. Florida is the only single-state MAC. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. If you also operate in another contractor’s state, say so on the first call — we map both.
The 96.5% hematogel figure on our wound materials is product-level clinical experience, not a New Orleans trial. Local outcomes stay with the treating physician. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Use that rate for inventory math, not for ads.
CDC PLACES (2023, crude prevalence) estimates 15.1% of adults — 3.1 points above the U.S. 12% figure. Obesity is 34%; arthritis is 25.3%. That is place-level BRFSS modeling, not a clinic census and not a New Orleans trial.
No. Hawk Medical does not distribute products as “stem cell therapy.” HCT/P 361 allografts are regulated under 21 CFR 1271 for homologous use and minimal manipulation. PRP is autologous. Marketing that blurs those lanes is a compliance problem in every state, including Louisiana.
City-proper counts are unambiguous and match the URL slug. MSA figures change with OMB delineations and would be easy to get wrong. We would rather under-claim than invent a metro number.
Point-of-care spin, kit handling, and documentation basics. Injection technique, privileging, and ultrasound guidance remain the clinic’s clinical education path in Louisiana.
Start with one protocol — one joint or one wound type — for 90 days. CDC PLACES (2023, crude) estimates 15.1% of adults in New Orleans have diagnosed diabetes — 3.1 points above the U.S. 12% figure. Name a staff owner for photos, lots, and centrifuge logs. Then expand the fridge.
Contact us to learn how Hawk Medical supports practices in New Orleans, LA.
Hawk Medical is a national distributor. Joe Bradley’s clinic uses the same product classes. What is local for New Orleans is JH geography and published epidemiology — not a street address.
CDC PLACES 2023 crude rate for New Orleans — 3.1 points above the U.S. 12% figure. Planning input, not an outcomes claim.
Louisiana Part B wound biologics follow this contractor (siblings: AR, CO, MS, NM, OK, TX). We train to the articles. We do not write coverage.
PLACES crude adult arthritis in New Orleans. Useful for joint-program math; still needs a diagnosis and privileging.
No New Orleans storefront. Joe Bradley is an active practice owner. joint preservation therapy stays in its regulatory lane — not “FDA-approved stem cell therapy.”
Experience the difference of working with a distributor who understands your practice because we operate one ourselves.